Keywords: Janssen, Johnson & Johnson, Risperdal, Penalty, Bayer, Xarelto, EU filing, Threshold Pharma, Merck KGaA, Milestone

News briefs on Janssen, Bayer and Merck KGaA/Threshold

Article | 12 April 2012

Print This

In the USA, the Arkansas jury found that the Janssen unit of US health care giant Johnson & Johnson (NYSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in